If you're registered, you can access the medicines optimisation/medication safety dashboards using ePACT2.
If you are not registered for ePACT2, you can access medicines optimisation/medication safety dashboards via Catalyst - public insight portal
The Medicines Optimisation dashboard was formally managed by the Medicines Optimisation Intelligence Group (MOIG), which was chaired by Bruce Warner, Deputy Chief Pharmacist, NHS England. The MOIG is no longer in operation; however NHS England has requested that the NHS Business Services Authority (NHSBSA) continue to refresh this dashboard and the comparators included where feasible.
The Medicines Value Programme (MVP) has been set up to improve health outcomes from medicines and ensure we are getting the best value from the NHS medicines bill. One of the work streams of the MVP is optimising the use of medicines. Medicines Optimisation looks at the value which medicines deliver, making sure they are clinically-effective and cost-effective.
The goal of medicines optimisation is to help patients to:
- get the right choice of medicines, at the right time
- access treatment that is clinically effective, based on the latest scientific discovery, at as low a price as possible
- improve their outcomes
- take their medicines correctly
- avoid taking unnecessary medicines
- reduce wastage of medicines
- and improve medicines safety
Further information regarding the Medicines Value Programme can be found on the NHS England website https://www.england.nhs.uk/medicines/value-programme/
This dashboard brings together a range of data relating to variation in medicines use and prescribing to inform the strategic medicines optimisation plans of CCGs and Trusts.
It helps support NHS organisations in highlighting variation and facilitates discussion on how they compare with others across a range of comparators.
It is not intended as a performance measurement tool and there are no targets.
Medicines optimisation dashboard now includes a link to the Medication Safety dashboard that includes a set of prescribing indicators which have been developed as part of a programme of work to reduce medication error and promote safer user of medicines, including prescribing, dispensing, administration and monitoring.
The programme of work is in response to the 'World Health Organisation' (WHO) global challenge - 'Medication with Harm'.
More information can be found in the report of the short life working group.
The analysis is an experimental piece of work. This is the first time prescribing data has been linked to admissions data at a national level.